MYB and leukemia: The incomplete penetrance of the leukemia development induced by Myb and BCR/ABL and the monoclonal origins of the resulting leukemias (Supplementary Figure 6) also suggest that additional mutations, potentially with effects of increasing proliferation and/or inhibiting apoptosis, are required for the transformation of GMPs.